Dr. James Leung

D.D.S. | Dentist



  
  839 58th St Apt 1, Brooklyn
  New York, 11220-3679

  718-290-2908    347-750-8647 Maps & Directions
Dr. James Leung is a Brooklyn, New York based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 839 58th St Apt 1, Brooklyn. Patients can reach him at 718-290-2908.
Dr. James Leung is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. James Leung speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. James Leung
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:839 58th St Apt 1, Brooklyn,
New York, 11220-3679
Phone:718-290-2908
Fax:347-750-8647
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6305145764
Enrollment ID: I20160506000157
NPI Number: 1376668665
NPI Enumeration Date: 19 Mar, 2007
NPI Last Update On: 25 Jun, 2012

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 839 58th St Apt 1,
Brooklyn, New York
Zip: 11220-3679
Phone Number: 718-290-2908
Fax Number: 347-750-8647
Patients can reach Dr. James Leung at 839 58th St Apt 1, Brooklyn, New York or can call to book an appointment on 718-290-2908. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.

Comments/ Reviews: